ABC transporters in cancer: more than just drug efflux pumps
- PMID: 20075923
- DOI: 10.1038/nrc2789
ABC transporters in cancer: more than just drug efflux pumps
Abstract
Multidrug transporter proteins are best known for their contributions to chemoresistance through the efflux of anticancer drugs from cancer cells. However, a considerable body of evidence also points to their importance in cancer extending beyond drug transport to fundamental roles in tumour biology. Currently, much of the evidence for these additional roles is correlative and definitive studies are needed to confirm causality. We propose that delineating the precise roles of these transporters in tumorigenesis and treatment response will be important for the development of more effective targeted therapies.
Comment in
-
The ABC of glycosylation.Nat Rev Cancer. 2010 Jul;10(7):523. doi: 10.1038/nrc2789-c1. Epub 2010 Jun 10. Nat Rev Cancer. 2010. PMID: 20535133 No abstract available.
Similar articles
-
Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.Biomed Pharmacother. 2018 Apr;100:335-348. doi: 10.1016/j.biopha.2018.02.038. Epub 2018 Feb 16. Biomed Pharmacother. 2018. PMID: 29453043 Review.
-
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.Cancer Lett. 2016 Jan 1;370(1):153-64. doi: 10.1016/j.canlet.2015.10.010. Epub 2015 Oct 20. Cancer Lett. 2016. PMID: 26499806 Review.
-
Revisiting the ABCs of multidrug resistance in cancer chemotherapy.Curr Pharm Biotechnol. 2011 Apr;12(4):570-94. doi: 10.2174/138920111795164048. Curr Pharm Biotechnol. 2011. PMID: 21118094 Review.
-
ABC transporters as cancer drivers: Potential functions in cancer development.Biochim Biophys Acta Gen Subj. 2019 Jan;1863(1):52-60. doi: 10.1016/j.bbagen.2018.09.019. Epub 2018 Sep 27. Biochim Biophys Acta Gen Subj. 2019. PMID: 30268729 Review.
-
Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.Curr Opin Pharmacol. 2006 Aug;6(4):350-4. doi: 10.1016/j.coph.2006.01.009. Epub 2006 May 11. Curr Opin Pharmacol. 2006. PMID: 16690355 Review.
Cited by
-
Tetrahydroquinoline/4,5-Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2).ChemMedChem. 2021 Sep 6;16(17):2686-2694. doi: 10.1002/cmdc.202100188. Epub 2021 May 18. ChemMedChem. 2021. PMID: 33844464 Free PMC article.
-
Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin.Pharmaceuticals (Basel). 2023 Nov 9;16(11):1582. doi: 10.3390/ph16111582. Pharmaceuticals (Basel). 2023. PMID: 38004447 Free PMC article.
-
Defining the microbial effluxome in the content of the host-microbiome interaction.Front Pharmacol. 2015 Feb 19;6:31. doi: 10.3389/fphar.2015.00031. eCollection 2015. Front Pharmacol. 2015. PMID: 25745401 Free PMC article. No abstract available.
-
Pathway-based analysis using genome-wide association data from a Korean non-small cell lung cancer study.PLoS One. 2013 Jun 6;8(6):e65396. doi: 10.1371/journal.pone.0065396. Print 2013. PLoS One. 2013. PMID: 23762359 Free PMC article.
-
ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells.Exp Ther Med. 2022 Oct 18;24(6):722. doi: 10.3892/etm.2022.11658. eCollection 2022 Dec. Exp Ther Med. 2022. PMID: 36340608 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources